Showing 1,101 - 1,120 results of 100,292 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( 5 ((non decrease) OR (nn decrease)) ))', query time: 1.40s Refine Results
  1. 1101
  2. 1102
  3. 1103
  4. 1104
  5. 1105
  6. 1106
  7. 1107
  8. 1108
  9. 1109
  10. 1110

    Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses by Matthew Zirui Tay (3140493)

    Published 2016
    “…For instance, in the RV144 vaccine trial that achieved partial efficacy, Env IgA correlated with increased risk of HIV-1 infection (i.e. decreased vaccine efficacy), whereas V1-V2 IgG3 correlated with decreased risk of HIV-1 infection (i.e. increased vaccine efficacy). …”
  11. 1111
  12. 1112

    Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome by Azharuddin Sajid Syed Khaja (199670)

    Published 2011
    “…<div><h3>Background</h3><p>Wnt5a is a non-canonical secreted glycoprotein of the Wnt family that plays an important role in cancer development and progression. …”
  13. 1113

    Data extraction grid. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  14. 1114

    Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  15. 1115

    Inclusion criteria. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  16. 1116

    PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  17. 1117
  18. 1118

    Expression levels of JAM-A, VE-cadherin, and integrin-α5 in the I/R-injured hearts with or without TXL treatment. by Kang Qi (703361)

    Published 2018
    “…<p>I/R injury decreased the expression levels of JAM-A (A), VE-cadherin (B), and Integrin-α5 (C). …”
  19. 1119

    Decreased antihyperglycemic drug use driven by high out-of-pocket costs despite Medicare coverage gap closure by Mugdha Gokhale (8676201)

    Published 2020
    “…Re-initiation was lowest in the months before January (HR=0.4-0.5) among non-subsidized DPP-4i patients, demonstrating a strong seasonal pattern. …”
  20. 1120